Apply regulatory and licensing requirements governing pharmaceutical plant modernisation.
Planning the Expansion and Modernisation of Pharmaceutical Plants
Learn to design, measure and defend your organisation's approach to pharmaceutical plant modernisation.
📍 Tunis🗓️ 5 training days📚 4 modules🎓 Accredited certificate
5intensive training days
4scientific modules
8training sessions
32detailed points
Course Overview
Accreditation bodies assess pharmaceutical plant modernisation on documented evidence of consistent practice. Variation in this part of health and pharmaceutical services between shifts and sites is where avoidable harm lives. The programme converts the health and pharmaceutical services capability from an area of general awareness into a set of repeatable practices. Buying a tool rarely fixes pharmaceutical plant modernisation; the underlying capability has to be built internally first. Cases are chosen to expose the trade-offs in this strand of health and pharmaceutical services rather than to illustrate ideal conditions. It is pitched for practitioners with responsibility for the health and pharmaceutical services capability, not for observers of it. Where pharmaceutical plant modernisation is measured, it improves; where it is only discussed, it drifts. They acquire practical criteria for judging when the practice within health and pharmaceutical services is working and when it is only appearing to. Participants leave with a first-ninety-days plan for the wider health and pharmaceutical services agenda rather than a set of notes.
Expected Learning Outcomes
Apply root cause analysis to adverse events involving pharmaceutical plant modernisation.
Establish incident and near-miss reporting on pharmaceutical plant modernisation that staff trust.
Measure patient experience of pharmaceutical plant modernisation and act on what it shows.
Communicate the purpose of pharmaceutical plant modernisation to those who have to comply with it.
Build the internal capability for pharmaceutical plant modernisation rather than depending on external support indefinitely.
Build a concise clinical protocol for pharmaceutical plant modernisation that colleagues can follow without further explanation.
Who Should Attend
Those responsible for briefing external stakeholders on pharmaceutical plant modernisation.
Hospital and health facility managers accountable for pharmaceutical plant modernisation.
Public sector officials applying pharmaceutical plant modernisation within a regulated framework.
Finance managers costing services delivered through pharmaceutical plant modernisation.
Nursing managers and clinical supervisors delivering pharmaceutical plant modernisation.
Regulatory affairs specialists handling pharmaceutical plant modernisation.
Course Modules
Pharmaceutical plant modernisation: quality indicators and patient outcome
2 sessions · 8 pointsSession 1Auditing pharmaceutical plant modernisation at the bedside, not in the binder
- Build medication safety checks into pharmaceutical plant modernisation at the point of highest risk.
- Assign responsibility for keeping documentation of pharmaceutical plant modernisation current.
- Decide what will be stopped to create capacity for pharmaceutical plant modernisation.
- Define acceptance criteria for pharmaceutical plant modernisation in advance.
Session 2Comparing pharmaceutical plant modernisation with recognised practice
- Confirm patient data handled within pharmaceutical plant modernisation meets confidentiality obligations.
- Reduce unwarranted variation in pharmaceutical plant modernisation between shifts and sites.
- Confirm licensing and regulatory requirements applying to pharmaceutical plant modernisation are met.
- Close the loop: confirm changes to pharmaceutical plant modernisation improved the indicator they targeted.
Pharmaceutical plant modernisation: confidentiality, consent and ethics
2 sessions · 8 pointsSession 1Infection risk created by pharmaceutical plant modernisation
- Measure patient experience of pharmaceutical plant modernisation and feed it back to the team.
- Name a single owner for each element of pharmaceutical plant modernisation.
- Confirm competence and continuing development for staff delivering pharmaceutical plant modernisation.
- Prepare the response for the most likely failure in pharmaceutical plant modernisation.
Session 2Escalation and decision rights in pharmaceutical plant modernisation
- Confirm that reporting on pharmaceutical plant modernisation reaches the people who can act.
- Close out actions on pharmaceutical plant modernisation rather than leaving them open indefinitely.
- Build the internal briefing that explains pharmaceutical plant modernisation to those affected.
- Check that pharmaceutical plant modernisation still works when volumes rise unexpectedly.
Pharmaceutical plant modernisation: incident reporting, investigation and learning
2 sessions · 8 pointsSession 1Medication safety checkpoints inside pharmaceutical plant modernisation
- Define escalation criteria for deterioration detected through pharmaceutical plant modernisation.
- Estimate the resource pharmaceutical plant modernisation requires to run as designed.
- Build the competence framework that supports pharmaceutical plant modernisation.
- Assemble the accreditation evidence pack for pharmaceutical plant modernisation.
Session 2Choosing indicators for pharmaceutical plant modernisation that reflect outcome
- Map the handovers in pharmaceutical plant modernisation between functions and secure them.
- Apply structured root cause analysis to the last adverse event involving pharmaceutical plant modernisation.
- Define the trigger that would require pharmaceutical plant modernisation to be redesigned.
- Arrange the handover of pharmaceutical plant modernisation so capability survives staff changes.
Pharmaceutical plant modernisation: regulation, licensing and accreditation evidence
2 sessions · 8 pointsSession 1What to measure in pharmaceutical plant modernisation and what to ignore
- Map the clinical workflow for pharmaceutical plant modernisation as it is actually performed.
- Verify six months later that changes to pharmaceutical plant modernisation have held.
- Match staffing levels on pharmaceutical plant modernisation to measured demand across the week.
- Identify infection transmission risks created by pharmaceutical plant modernisation and control them.
Session 2Designing pharmaceutical plant modernisation so it helps rather than obstructs care
- Check that consent processes within pharmaceutical plant modernisation are genuinely informed.
- Audit pharmaceutical plant modernisation by observing practice, not by reading policy.
- Confirm the incident reporting route for pharmaceutical plant modernisation is quick and non-punitive.
- Rank the weaknesses in pharmaceutical plant modernisation by consequence rather than by ease of fixing.
Choose the package that suits you
Silver Package
At least 3 people
USD1,250
- Workshop or Program Participation
- Airport Transfers
- Customized Badge
- Expert Mentorship (Private Sessions)
- Supervision & Secretarial Services
- Accredited Certificate of Participation
- Complete Training Kit
- Coffee Break
- Closing Ceremony
Gold Package
At least 3 people
USD1,850
- 5-night stay in a 5-star hotel
- Workshop or Program Participation
- Airport Transfers
- Customized Badge
- Expert Mentorship (Private Sessions)
- Supervision & Secretarial Services
- Accredited Certificate of Participation
- Complete Training Kit
- Coffee Break
- Closing Ceremony
Complete your registration
We will contact you within one business day to confirm.